Introduction
Metabolic syndrome (MetS) is a state characterized by a cluster of metabolic abnormalities, including hypertension, hyperglycemia, dyslipidemia, and abdominal obesity, which collectively increase the risk of cardiovascular disease and type II diabetes [
1]. With a prevalence ranging from 10 to 50% among adults worldwide [
2], MetS poses a significant threat to global health, with alarming rates in specific populations, particularly among elderly individuals in the United States [
3]. The escalating prevalence of MetS and its association with increased mortality have made it a substantial burden on public health care systems and national finances [
4,
5].
One of the key hallmarks of MetS is insulin resistance, resulting from various lifestyle factors such as aging, obesity, sedentary behavior, smoking, and sleep apnea [
6]. Insulin resistance leads to elevated levels of reactive nitrogen oxides (RONS) and pro-inflammatory cytokines, triggering the activation of c-Jun N-terminal kinases (JNK1), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and mitogen-activated protein kinase (MAPK) [
7]. Consequently, oxidative stress occurs when there is an imbalance between the excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) and the body's antioxidant defense system [
8]. This oxidative stress damages cellular components, such as lipids, proteins, and DNA, contributing to the development of various metabolic disturbances [
9].
The potential roles of antioxidants, minerals, and vitamins in maintaining cellular health, reducing oxidative stress, and modulating metabolic pathways have been subjects of extensive research. These essential micronutrients have garnered considerable attention due to their proposed protective effects against specific cancers and other chronic diseases. Clinical data analysis has revealed low serum levels of retinyl esters, vitamin C, and carotenoids in MetS patients [
10]. Moreover, growing evidence suggests that high intakes of nutrients, such as vitamin C [
11], vitamin D [
12] and calcium [
13], could inhibit oxidative stress processes. Vitro experiments have shown that certain antioxidant nutrients reverse the inflammatory response caused by oxidative stress [
14]. However, results from clinical trials examining the effectiveness of antioxidants as disease preventive agents have been inconsistent, with some even showing potential harm [
15,
16]. These discrepancies may be attributed to limitations in observational studies (such as residual confounding and reverse causality) and challenges in randomized control trials, including low treatment compliance, inadequate dosages, short trial durations, and insufficient statistical power.
To overcome the bias of previous studies, we improved the study design through Mendelian randomization (MR) analysis, using genetic variation as an instrumental variable (IV), to establish reliable causal inferences between genetically predicted antioxidant, vitamin and mineral exposure levels and risk for MetS traits. By leveraging genetic variants as proxies for antioxidant, mineral, and vitamin levels, we aimed to obtain more robust and unbiased estimates of the potential causal effects of these micronutrients on MetS traits, thus contributing to a better understanding of preventive strategies for MetS and related conditions.
Discussion
In this MR analysis, we have presented compelling evidence suggesting that genetically predicted higher levels of circulating iron and magnesium were associated with an increased risk of MetS. Regarding individual MetS components, we found an inverse relationship between genetically predicted selenium levels and HDL-C levels. Additionally, genetically predicted vitamin D levels were inversely associated with FBG levels. Conversely, we observed positive associations between genetically predicted vitamin K1 levels and HDL-C levels, as well as between iron levels and TG levels. Suggestive evidence supported associations between genetically predicted beta-carotene, uric acid, selenium, circulating folate, vitamin B12, vitamin E and vitamin K1 and MetS traits.
The potential link between beta-carotene and a reduced risk of MetS has garnered support from previous observational studies [
41]. A cross-sectional study involving adolescents aged 12–19 years consistently found lower beta-carotene concentrations in the group with MetS compared to the group without the syndrome [
42]. The underlying mechanisms proposed to explain this association include the direct impact of β-carotene on adipocyte function through its intracellular metabolites, retinaldehyde, and all-trans retinoic acid, both acting as ligands for nuclear receptors, which in turn repress adipogenesis [
43]. Furthermore, compelling evidence suggested a correlation between genetic susceptibility to uric acid and an increased MetS risk, a finding consistent with prior prospective studies [
44]and meta-analyses [
45]. Yuan et al.'s meta-analysis, encompassing diverse populations, revealed a 30% rise in MetS risk for every 1 mg/dL increase in uric acid levels, demonstrating a notable linear dose–response relationship [
45]. Additionally, Liu et al. unveiled a consistent and linear causal connection between heightened uric acid and the incidence of MetS, leading to the postulation of uric acid as a prospective individualized predictor for identifying systemic/hepatic metabolic abnormalities [
46]. Therefore, lowering uric acid levels may be a potential therapeutic approach to prevent complex metabolic disorders.
Data on the associations of vitamins with MetS traits are scarce. We observed that genetic predisposition to higher vitamin K1 levels were associated with a decreased risk of low HDL-C level. Evidence from a cross-sectional and longitudinal analysis of a ten-year follow-up cohort suggests that high menaquinone intake and high vitamin K levels were associated with a lower incidence of MetS [
47]. These associations were primarily driven by triglycerides and waist circumference. A cross-sectional study examined the relationship between phylloquinone intake and MetS and found that high phylloquinone intake was associated with lower prevalence of MetS (odds ratio = 0.72; 95% CI 0.25–2.09), although the association did not reach statistical significance [
48]. Pan and Jackson [
48] also studied the components of MetS and found that high phylloquinone intake was associated with a lower risk of low HDL-C, hypertriglyceridemia, and hyperglycemia. Epidemiological data concerning the association between vitamin D and FBG levels have produced inconsistent results, with both positive [
49] and null findings [
50] reported. Our study provides evidence supporting a causal role for vitamin D in MetS traits. In contrast, our study provides compelling evidence supporting a causal role for vitamin D in MetS traits. This role may be attributed to the mechanism of action of vitamin D on various physiological parameters. These mechanisms include the improvement of arterial stiffness, reduction of renin–angiotensin–aldosterone system activity, modulation of parathyroid hormone levels, regulation of inflammatory cytokines, enhancement of lipoprotein lipase activity, and promotion of improved phospholipid metabolism and mitochondrial oxidation [
51]. Researches on vitamin K1 levels and FBG levels has not yet reached a unified conclusion. A randomized, controlled, crossover study inhibiting serum undercarboxylated osteocalcin (ucOC) by consumption of green leafy vegetables had no negative effects on glycemic status [
47]. Therefore, further exploratory basic science or clinical inquiries are warranted to comprehensively understand the mechanism by which vitamin K1 contributes to the elevation of FBG levels.
The role of folate in hypertension risk has been previously noted. In line with our MR study results, a prospective cohort study involving 93,803 younger women aged 27 to 44 years from the Nurses' Health Study II and 62,260 older women aged 43 to 70 years from the Nurses' Health Study I demonstrated that higher total folate intake was associated with a reduced risk of incident hypertension, especially among younger women [
52]. Mechanistically, folate deficiency can lead to the blockage of insulin synthesis and secretion in cultured β cells due to increased reactive oxygen species production and pro-apoptotic changes [
53]. Conversely, folic acid has been shown to improve beta cell function by reducing oxidative stress, which is believed to contribute to the reduced risk of cardiovascular disease and diabetes by lowering insulinemia [
54]. As for vitamin E, evidence from prospective cohort based on 24-h dietary records revealed a reverse J-shaped association between dietary vitamin E intake and new-onset hypertension in general Chinese adults [
55]. As our MR study was not specifically designed to detect nonlinear associations, we can only infer that excessive vitamin E intake may be a causal risk factor for hypertension. Furthermore, our study's novel finding of a statistically potentially positive association between genetically predicted circulating vitamin B12 levels and FBG warrants confirmation through further research.
The role of minerals on MetS traits has been explored in previous observational studies [
56,
57]. Findings from a cross-sectional study with 5323 participants from four Chinese megacities indicated that a positive association between high dietary iron intake and metabolic abnormalities [
56]. Additionally, animal experiments have suggested that elevated dietary iron intake may lead to insulin resistance and oxidative stress [
57]. Laboratory studies have provided insights into a possible mechanism, indicating that free iron possesses strong pro-oxidative properties, leading to oxidative damage and apoptosis through Fenton chemistry, resulting in the generation of RONs [
58]. Contrasting our results, dietary magnesium intake has been reported to show an inverse association with MetS risk in studies conducted on both US [
59] and Arab adults [
60]. However, another Italian cross-sectional study did not observe such a statistical association [
61]. In a 32-participant double-blind, placebo-controlled randomized study, the supplementation of magnesium did not substantially alter cardiometabolic biomarkers [
62]. We posit that the disparities in findings could be attributed to magnesium's interplay with other nutrients. Interestingly, utilizing a validated genetic instrument, we observed that a genetic predisposition to high circulating magnesium was associated with an increased risk of MetS, suggesting that disturbances in magnesium metabolism may play a role in the pathological process of MetS pathogenesis.
The epidemiological data on the association between selenium and HDL-C levels show inconsistency, with both positive and null results reported. Our study provides evidence supporting a causal role for selenium in MetS traits. Recently, a case–control study from China discovered a positive association between selenium and MetS [
63]. A recent meta-analysis demonstrated a positive relationship between selenium exposure and diabetes in epidemiological and experimental studies [
64]. The positive association between selenium and hyperglycemia aligns with previous evidence that high selenium may have a diabetogenic effect. Our findings are consistent with this, as we observed that higher genetically predicted selenium levels were associated with increased odds of hypertriglyceridemia and a lower risk of developing low HDL-C levels [
65]. The underlying mechanism explaining this association lies in the impact of selenium levels on the expression and activity of selenoproteins [
66]. Excessive selenium levels may lead to an upsurge in ROS production, attributed to the increase of inorganic selenium in plasma [
67]. The subsequent increase in ROS can lead to oxidative stress and insulin resistance [
68], both of which are potential etiology of MetS.
The present study has several strengths, one of the main ones being the MR design. The study design reduced residual confounding and reversed causality, and strengthened causal inferences in the observed exposure-MetS traits associations. Another strength is that we have implemented the most comprehensive exposure dataset and the broadest summary-level data on MetS and its components, with no or very limited overlap between exposure and outcome data, so the ability to investigate causality is high, the type I error rate is low, and the estimated magnitude of effect is more accurate. The existing literature on the efficacy of micronutrient supplementation as a treatment for metabolic disorders is currently limited, comprising only a handful of small-scale studies focusing on specific patient subgroups. This scarcity of evidence poses challenges in formulating precise recommendations regarding nutritional supplementation. The results of this study will complement the evidence from current observational studies supporting causal relationships between circulating micronutrients and the development of metabolic disorders, which will contribute to the field of research in the nutritional prevention of MetS.
However, our study also has limitations. Firstly, we still cannot eliminate potential pleiotropic effects that may be masked by a few instrumental variables, although MR-egger intercepts showed little horizontal pleiotropy. Secondly, heterogeneity for some exposures was indicated by Cochran's Q values in the MR analysis. We therefore performed the MR-PRESSO analysis and the results indicated the stability of the observed associations. Thirdly, we restricted our analysis to individuals of European ancestry, which reduced potential bias introduced by demographics but limited the generalizability of our findings to other populations.
In conclusion, the results provided by this MR study support a causal relationship between multiple antioxidants, vitamins, and minerals and the risk of MetS and its components. Strategies targeting these modifiable factors, avoiding excessive urid acid, iron, magnesium, and selenium intake and increasing beta-carotene, vitamin K1 intake, can prevent MetS and lipid abnormalities and reduce the corresponding disease burden, and increasing vitamin D intake can reduce FBG level. Vitamin K1 have the potential to be chemoprotection against the pathogenesis of MetS traits. Our research might contribute significantly to the development of evidence-based recommendations for nutritional supplementation strategies targeting metabolic disorders.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.